Literature DB >> 6809317

Toxicology of daunorubicin in animals and man.

R J Maral, M Jouanne.   

Abstract

The toxic effects of daunorubicin with specific reference to acute, subacute, and long-term studies in animals are reviewed, and its clinical toxicity is considered. We emphasize the importance of hematologic toxicity and infections when treating with daunorubicin. A summary of the work done on detoxifying activities of certain compounds is presented, and the activities that increase the toxic effects of daunorubicin are discussed. Finally, the immunosuppressive, mutagenic, teratogenic, and carcinogenic activities of daunorubicin are mentioned.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6809317

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  9 in total

1.  Expression of a human multidrug resistance cDNA (MDR1) in the bone marrow of transgenic mice: resistance to daunomycin-induced leukopenia.

Authors:  H Galski; M Sullivan; M C Willingham; K V Chin; M M Gottesman; I Pastan; G T Merlino
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

2.  Transgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance.

Authors:  G H Mickisch; G T Merlino; H Galski; M M Gottesman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

Review 3.  Clinical pharmacokinetics of doxorubicin.

Authors:  P A Speth; Q G van Hoesel; C Haanen
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

4.  Detection of adriamycin-induced cardiotoxicity in cultured heart cells with technetium 99m-SESTAMIBI.

Authors:  D Piwnica-Worms; M L Chiu; J F Kronauge
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

5.  Effect of amrinone on anthracycline-induced lethal and cardiac toxicity in mice and rats.

Authors:  F Villani; C Manzotti; M Mella; E Monti; G Savi; F Zunino
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

6.  Daunomycin in the treatment of experimental proliferative vitreoretinopathy: retinal toxicity of intravitreal daunomycin in the rabbit.

Authors:  M Santana; P Wiedemann; M Kirmani; D S Minckler; R Patterson; N Sorgente; S J Ryan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1984       Impact factor: 3.117

7.  Assessment of left ventricular diastolic function in patients receiving anthracycline therapy.

Authors:  S Parmentier; J A Melin; L Piret; C Beckers
Journal:  Eur J Nucl Med       Date:  1988

8.  Effect of coenzyme Q10 on the disposition of doxorubicin in rats.

Authors:  Qingyu Zhou; Balram Chowbay
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Jul-Sep       Impact factor: 2.569

9.  Autophagy inhibition enhances daunorubicin-induced apoptosis in K562 cells.

Authors:  Weidong Han; Jie Sun; Lifeng Feng; KaiFeng Wang; Da Li; Qin Pan; Yan Chen; Wei Jin; Xian Wang; Hongming Pan; Hongchuan Jin
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.